位置:首页 > 蛋白库 > ROQN_PENRW
ROQN_PENRW
ID   ROQN_PENRW              Reviewed;         288 AA.
AC   B6HJU2;
DT   08-JUN-2016, integrated into UniProtKB/Swiss-Prot.
DT   16-DEC-2008, sequence version 1.
DT   03-AUG-2022, entry version 65.
DE   RecName: Full=Glandicoline B O-methyltransferase roqN {ECO:0000305};
DE            EC=3.1.1.- {ECO:0000269|PubMed:22118684, ECO:0000269|PubMed:23776469, ECO:0000269|PubMed:24225953};
DE   AltName: Full=Roquefortine/meleagrin synthesis protein N {ECO:0000303|PubMed:23776469};
GN   Name=roqN {ECO:0000303|PubMed:23776469};
GN   Synonyms=gmt {ECO:0000303|PubMed:22118684}; ORFNames=Pc21g15440;
OS   Penicillium rubens (strain ATCC 28089 / DSM 1075 / NRRL 1951 / Wisconsin
OS   54-1255) (Penicillium chrysogenum).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;
OC   Eurotiomycetidae; Eurotiales; Aspergillaceae; Penicillium;
OC   Penicillium chrysogenum species complex.
OX   NCBI_TaxID=500485;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 28089 / DSM 1075 / NRRL 1951 / Wisconsin 54-1255;
RX   PubMed=18820685; DOI=10.1038/nbt.1498;
RA   van den Berg M.A., Albang R., Albermann K., Badger J.H., Daran J.-M.,
RA   Driessen A.J.M., Garcia-Estrada C., Fedorova N.D., Harris D.M.,
RA   Heijne W.H.M., Joardar V.S., Kiel J.A.K.W., Kovalchuk A., Martin J.F.,
RA   Nierman W.C., Nijland J.G., Pronk J.T., Roubos J.A., van der Klei I.J.,
RA   van Peij N.N.M.E., Veenhuis M., von Doehren H., Wagner C., Wortman J.R.,
RA   Bovenberg R.A.L.;
RT   "Genome sequencing and analysis of the filamentous fungus Penicillium
RT   chrysogenum.";
RL   Nat. Biotechnol. 26:1161-1168(2008).
RN   [2]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=22118684; DOI=10.1016/j.chembiol.2011.08.012;
RA   Garcia-Estrada C., Ullan R.V., Albillos S.M., Fernandez-Bodega M.A.,
RA   Durek P., von Doehren H., Martin J.F.;
RT   "A single cluster of coregulated genes encodes the biosynthesis of the
RT   mycotoxins roquefortine C and meleagrin in Penicillium chrysogenum.";
RL   Chem. Biol. 18:1499-1512(2011).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=24225953; DOI=10.1074/jbc.m113.512665;
RA   Ries M.I., Ali H., Lankhorst P.P., Hankemeier T., Bovenberg R.A.,
RA   Driessen A.J., Vreeken R.J.;
RT   "Novel key metabolites reveal further branching of the
RT   roquefortine/meleagrin biosynthetic pathway.";
RL   J. Biol. Chem. 288:37289-37295(2013).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, INDUCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=23776469; DOI=10.1371/journal.pone.0065328;
RA   Ali H., Ries M.I., Nijland J.G., Lankhorst P.P., Hankemeier T.,
RA   Bovenberg R.A., Vreeken R.J., Driessen A.J.;
RT   "A branched biosynthetic pathway is involved in production of roquefortine
RT   and related compounds in Penicillium chrysogenum.";
RL   PLoS ONE 8:E65328-E65328(2013).
RN   [5]
RP   BIOTECHNOLOGY.
RX   PubMed=26692349; DOI=10.1016/j.bmc.2015.11.038;
RA   Mady M.S., Mohyeldin M.M., Ebrahim H.Y., Elsayed H.E., Houssen W.E.,
RA   Haggag E.G., Soliman R.F., El Sayed K.A.;
RT   "The indole alkaloid meleagrin, from the olive tree endophytic fungus
RT   Penicillium chrysogenum, as a novel lead for the control of c-Met-dependent
RT   breast cancer proliferation, migration and invasion.";
RL   Bioorg. Med. Chem. 24:113-122(2016).
CC   -!- FUNCTION: Glandicoline B O-methyltransferase; part of the gene cluster
CC       that mediates the biosynthesis of the mycotoxin meleagrin
CC       (PubMed:22118684, PubMed:23776469). The first stage is catalyzed by the
CC       dipeptide synthase roqA which condenses histidine and tryptophan to
CC       produce histidyltryptophanyldiketopiperazine (HTD) (PubMed:22118684,
CC       PubMed:23776469). HTD is then converted to roquefortine C through two
CC       possible pathways (PubMed:23776469). In the first pathway,
CC       prenyltransferase roqD transforms HTD to the intermediate roquefortine
CC       D, which is in turn converted to roquefortine C by the cytochrome P450
CC       monooxygenase roqR (PubMed:23776469). In the second pathway, HTD is
CC       first converted to the intermediate dehydrohistidyltryptophanyldi-
CC       ketopiperazine (DHTD) by roqR which is then prenylated by roqD to form
CC       roquefortine C (PubMed:23776469). Roquefortine C can be further
CC       transformed to meleagrin via three more reactions including oxydation
CC       to glandicolin A by roqM, which is further reduced to glandicoline B by
CC       roqO (PubMed:23776469). Finally, glandicoline B is converted to
CC       meleagrin by the glandicoline B O-methyltransferase roqN
CC       (PubMed:22118684, PubMed:23776469). More studies identified further
CC       branching and additional metabolites produced by the
CC       roquefortine/meleagrin cluster, including roquefortine F, roquefortine
CC       L, roquefortine M, roquefortine N and neoxaline (PubMed:24225953).
CC       {ECO:0000269|PubMed:22118684, ECO:0000269|PubMed:23776469,
CC       ECO:0000269|PubMed:24225953}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glandicoline B + S-adenosyl-L-methionine = H(+) + meleagrin +
CC         S-adenosyl-L-homocysteine; Xref=Rhea:RHEA:51732, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:70399,
CC         ChEBI:CHEBI:134347; Evidence={ECO:0000269|PubMed:22118684};
CC   -!- PATHWAY: Alkaloid biosynthesis. {ECO:0000269|PubMed:22118684,
CC       ECO:0000269|PubMed:23776469, ECO:0000269|PubMed:24225953}.
CC   -!- INDUCTION: Expression is decreased in presence of phenylacetic acid
CC       (PAA) (PubMed:23776469). {ECO:0000269|PubMed:23776469}.
CC   -!- DISRUPTION PHENOTYPE: Leads to the accumulation of glandicoline B
CC       (PubMed:22118684, PubMed:23776469). Does not affect the production of
CC       roquefortine C but decreases the production of meleagrin
CC       (PubMed:22118684, PubMed:24225953,PubMed:23776469).
CC       {ECO:0000269|PubMed:22118684, ECO:0000269|PubMed:23776469,
CC       ECO:0000269|PubMed:24225953}.
CC   -!- BIOTECHNOLOGY: The indole alkaloid meleagrin was shown to be a good
CC       candidate to control c-Met-dependent breast cancer proliferation,
CC       migration and invasion (PubMed:26692349).
CC       {ECO:0000269|PubMed:26692349}.
CC   -!- SIMILARITY: Belongs to the class I-like SAM-binding methyltransferase
CC       superfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AM920436; CAP96441.1; -; Genomic_DNA.
DR   RefSeq; XP_002568554.1; XM_002568508.1.
DR   PDB; 5W7M; X-ray; 1.70 A; A=1-288.
DR   PDBsum; 5W7M; -.
DR   AlphaFoldDB; B6HJU2; -.
DR   SMR; B6HJU2; -.
DR   STRING; 1108849.XP_002568554.1; -.
DR   EnsemblFungi; CAP96441; CAP96441; PCH_Pc21g15440.
DR   GeneID; 8315545; -.
DR   KEGG; pcs:Pc21g15440; -.
DR   VEuPathDB; FungiDB:PCH_Pc21g15440; -.
DR   eggNOG; ENOG502S4V1; Eukaryota.
DR   HOGENOM; CLU_065416_0_0_1; -.
DR   OMA; HEMLPDW; -.
DR   OrthoDB; 785883at2759; -.
DR   BioCyc; PCHR:PC21G15440-MON; -.
DR   Proteomes; UP000000724; Contig Pc00c21.
DR   GO; GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW.
DR   GO; GO:0008168; F:methyltransferase activity; IEA:UniProtKB-KW.
DR   GO; GO:0032259; P:methylation; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.50.150; -; 1.
DR   InterPro; IPR041698; Methyltransf_25.
DR   InterPro; IPR029063; SAM-dependent_MTases_sf.
DR   Pfam; PF13649; Methyltransf_25; 1.
DR   SUPFAM; SSF53335; SSF53335; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Hydrolase; Methyltransferase; Reference proteome;
KW   S-adenosyl-L-methionine; Transferase.
FT   CHAIN           1..288
FT                   /note="Glandicoline B O-methyltransferase roqN"
FT                   /id="PRO_0000436348"
FT   BINDING         57
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000250|UniProtKB:A6VDI6"
FT   BINDING         82
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000250|UniProtKB:A6VDI6"
FT   BINDING         109..110
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000250|UniProtKB:A6VDI6"
FT   HELIX           17..27
FT                   /evidence="ECO:0007829|PDB:5W7M"
FT   HELIX           28..30
FT                   /evidence="ECO:0007829|PDB:5W7M"
FT   HELIX           31..38
FT                   /evidence="ECO:0007829|PDB:5W7M"
FT   HELIX           40..42
FT                   /evidence="ECO:0007829|PDB:5W7M"
FT   STRAND          46..53
FT                   /evidence="ECO:0007829|PDB:5W7M"
FT   TURN            56..58
FT                   /evidence="ECO:0007829|PDB:5W7M"
FT   HELIX           59..67
FT                   /evidence="ECO:0007829|PDB:5W7M"
FT   TURN            68..70
FT                   /evidence="ECO:0007829|PDB:5W7M"
FT   HELIX           73..75
FT                   /evidence="ECO:0007829|PDB:5W7M"
FT   STRAND          76..83
FT                   /evidence="ECO:0007829|PDB:5W7M"
FT   HELIX           85..98
FT                   /evidence="ECO:0007829|PDB:5W7M"
FT   STRAND          103..107
FT                   /evidence="ECO:0007829|PDB:5W7M"
FT   STRAND          120..127
FT                   /evidence="ECO:0007829|PDB:5W7M"
FT   HELIX           129..131
FT                   /evidence="ECO:0007829|PDB:5W7M"
FT   HELIX           135..145
FT                   /evidence="ECO:0007829|PDB:5W7M"
FT   STRAND          146..159
FT                   /evidence="ECO:0007829|PDB:5W7M"
FT   HELIX           162..171
FT                   /evidence="ECO:0007829|PDB:5W7M"
FT   STRAND          173..175
FT                   /evidence="ECO:0007829|PDB:5W7M"
FT   HELIX           182..186
FT                   /evidence="ECO:0007829|PDB:5W7M"
FT   STRAND          188..190
FT                   /evidence="ECO:0007829|PDB:5W7M"
FT   TURN            191..194
FT                   /evidence="ECO:0007829|PDB:5W7M"
FT   HELIX           196..206
FT                   /evidence="ECO:0007829|PDB:5W7M"
FT   STRAND          209..223
FT                   /evidence="ECO:0007829|PDB:5W7M"
FT   HELIX           224..231
FT                   /evidence="ECO:0007829|PDB:5W7M"
FT   HELIX           232..234
FT                   /evidence="ECO:0007829|PDB:5W7M"
FT   HELIX           235..242
FT                   /evidence="ECO:0007829|PDB:5W7M"
FT   HELIX           245..251
FT                   /evidence="ECO:0007829|PDB:5W7M"
FT   HELIX           252..254
FT                   /evidence="ECO:0007829|PDB:5W7M"
FT   HELIX           255..267
FT                   /evidence="ECO:0007829|PDB:5W7M"
FT   STRAND          272..285
FT                   /evidence="ECO:0007829|PDB:5W7M"
SQ   SEQUENCE   288 AA;  32277 MW;  825514F747E2E58C CRC64;
     MTRATNFTEL YAGKGILDTY MVAEKITRYY TQDLIQLSGL SESSLTPLVI LDLACGTGVV
     SDALHDMLNF QPKGNWELTC GDISTELTGH VKQKILERGW ENSIAKVVDA QNTELPTGHY
     THVFAALAFT SFPDTYAAMK EVMRILQPGG TLTISTWQRT EWLAVVEAAV AIIPADLPFP
     TTKEFMSCMN PGWDSEDYVH SRFEEAGFHS VQVTTISKQF ETSVEDLYKI AQPVIPIIVS
     KWWNQEQRDK YENDILPALQ RHLNETYGEN GLVPQEWTAV FATGQKGS
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025